- all aspects of medical treatment of breast cancer
- neo-adjuvant therapies
- adjuvant therapies
- treatment of advanced and metastatic disease
- novel treatments and targeted therapies
Dr Alistair Ring is a Consultant Medical Oncologist at The Royal Marsden. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at The Royal Marsden, St George’s and Guy’s Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research (ICR) at the University of London.
In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant Medical Oncologist at The Royal Marsden.
He has specialist interests in the management of metastatic and early breast cancer and the management of cancer in older patients. He has a major interest in research, and is UK lead for a number of research studies examining the roles of aspirin and modern targeted drugs in the management of breast cancer. He is Chair of the Committee for Clinical Research at The Royal Marsden and the ICR. Dr Ring has published widely in peer-reviewed journals and in 2015, edited the textbook Problem Solving in Older Cancer Patients and in 2017 Breast Cancer Survivorship.
He is a member of the National Cancer Research Institute (NCRI) Breast Clinical Studies Group, and previous chair of the NCRI Advanced Breast Cancer subgroup, which oversees trials for advanced breast cancer in the UK. He is a member of the American Society of Clinical Oncology.
In 2018 Dr Ring was appointed Honorary Reader in Breast Cancer Clinical Trials, at the Institute of Cancer Research.